W hen the body is challenged by pathogens during infections, the first-line defense for the host is provided by the innate immune system which encompasses various cell types such as macrophages, dendritic cells (DCs), and natural killer (NK) cells. These cells express the so-called pattern recognition receptors (PRRs) including Toll-Like receptors (TLRs), NOD-like receptors (NLRs), and RIG-I-like receptors (RLRs) on their surface and can recognize pathogen-associated molecular patterns (PAMPs) of bacterial and viral pathogens. [1, 2] After recognition of PAMPs by PRRs, diverse signaling pathways can be initiated resulting in the induction of pro-and anti-inflammatory cytokines and chemokines, which are essential for the host defense. Current literature evidence suggests a relationship between the cellular immune reaction and its regulation by cellular stress pathways, often activated in infections and chronic diseases as survival mechanisms activated by cells in response to stressful stimuli, as reviewed elsewhere. [3] In this context, some endogenous intracellular molecules from the host can be secreted into the extracellular environment and they control the function of immune cells under pathological situations. During inflammatory conditions, extracellular ATP, which is classically associated with cellular energy metabolism, is often reported to be released passively following cellular stress or cell death. Extracellular ATP and the related purine and pyrimidine nucleotides exert their functions via signaling through membrane-bound purinergic P2 receptors. These receptors are widely expressed throughout the body on various immune and non-immune cells. [4] The P2 receptors are subdivided into two families: the G protein-coupled P2Y receptors and P2X receptors with ligand-gated ion channels. [5, 6] The purinergic receptor P2X ligand-gated ion channel 7 (P2X7) is ubiquitously expressed in almost all tissues and organs of the body, [4] with the highest distribution in the immune cells of monocyte-macrophage origin. [7] Besides the immune cells that are committed with critical protective responses since the early phases of microbial infection or acute tissue trauma, P2X7 receptor has also been reported to be present in fibroblasts, [8] endothelial cells, [9] exocrine glands (salivary glands and pancreas), [10] as well as in epithelial cells. [11] In fact, once activated by extracellular ATP, the P2X7 receptor opens a nonselective cationic channel that allows K + efflux and Na + and Ca 2+ influx. The activation of P2X7 receptor is also associated with pore formation depending on the concentration and time of ATP treatment and the cell type. [4, 12] Continuous stimulation of P2X7 receptor leads to apoptotic cell death in some cell types such as DCs and macrophages. [13, 14] Furthermore, a variety of downstream events have been described following P2X7 activation by its ligand, although these events require cell surface ATP levels > 100 μM sustained over a few minutes. [15] In cells previously primed by bacterial products, P2X7 receptor activation functions as a co-stimulus or as a second signal for the formation of NOD-like receptor protein 3 (NALP3) inflammasome [16] and secretion of interleukin (IL)-1β and IL-18, [17] production of reactive oxygen species, [18] and activation of nuclear factor kappa B (NF-κB). [19] In the first stage of inflammation, extracellular ATP mainly functions as a pro-inflammatory and immunostimulatory mediator in the microenvironment of damaged/ injured cells. The ATP may be part of a group of endogenous molecules, the so called "alarmins." [20, 21] These multifunctional molecules seem to act as a particular subgroup of endogenous danger signals since they exhibit both chemotactic and activating effects on leukocytes, displaying potent innate immune-enhancing activity. [20] ATP is present in the cell cytoplasm at millimolar concentrations, and is secreted during cellular stress or TLR activation, or is released in non-physiological necrotic cell death. [22] [23] [24] Extracellular ATP concentrations in the local inflammatory microenvironment of damaged cells can be markedly upregulated, contributing to the promotion of sustained inflammation and the initiation of primary immune responses. In other words, ATP, at high extracellular concentration, appears to be a natural endogenous adjuvant released from injured and dying cells, which initiates inflammation and has an exacerbating effect to amplify and sustain cell-mediated immunity through P2 receptor-mediated purinergic signaling. At an early phase following cell damage, when extracellular ATP levels are the highest, the P2 receptor that is most likely associated in sensing the purinergic danger is the P2X7 receptor, as previously reviewed. [25] In different inflammatory models, lack of P2X7 receptor was described to be involved in neutrophil recruitment deficiency, as demonstrated using P2X7 knockout mice in different situations. P2X7 receptor was reported to be involved in polymorphonuclear and mast cell recruitment and macrophage activation in a mouse model of lung injury, [26] and was also required for neutrophil accumulation in a mouse model of irritant contact dermatitis. [26, 27] Classically, P2X7 receptor would not be directly involved in polymorphonuclear leukocytes (PMNs) chemotaxis; but during bacterial challenge, ATP would be one of the mediators being secreted by both infected/stressed cells and bacteria. Expression of the P2X7 receptor actually enhances ATP release. [28] In this context, the release of ATP could facilitate neutrophil recruitment to the site of infection by (A) directly enhancing neutrophil chemotaxis, (B) inducing chemokine secretion by macrophages through the activation of P2Y receptors, and (C) inducing NLRP3 inflammasome activation and IL-1β secretion via P2X7 receptor, as proposed recently. [23] It was also demonstrated that ATP can be released by pannexin-1 hemichannels and that the autocrine feedback could happen by ATP ligation to P2Y2 receptor. [29] The ATP-P2Y2 ligation was shown to be involved in CXCL8 production (classically involved in neutrophil chemotaxis), which can be regulated by ectonucleotidases, [30, 31] since these enzymes can control extracellular ATP availability [ Figure 1 ].
The role of P2X7 in acute infection
It was hypothesized in a recent study that P2X7 receptor activation is the initial event leading to vascular dysfunction following lipopolysaccharide (LPS) treatment. It was also suggested that P2X7 receptor activation involves an initial upstream mechanism of LPS-induced vascular dysfunction, which is associated with IL-1β-mediated endothelial nitric oxide synthase (eNOS), cyclooxygenase-2 (COX2) activation, and tumor necrosis factor alpha (TNF-α) release. [32] It has also been demonstrated that purinergic signaling in the skin induces innate inflammation, leading to the differentiation of human T helper 17 (Th17) responses, which have implications in the pathogenesis and potential treatment of diseases, for example, psoriasis. [33] The influence of bacterially released ATP in the differentiation of Th17 cells in the intestinal mucosa was previously examined. [34] The delicate balance between the immune system and infectious agents requires a number of cellular players, in particular Th17 cells, which mediate an inflammatory response and are normally controlled by the simultaneous presence of regulatory T cells (Tregs). [35] The referred study showed that commensal bacteria can release large amounts of ATP (although not sufficient to deliver a "danger" inflammatory signal to the intestinal mucosa). The percentage of Th17 cells in bacteria-free mice was upregulated by treating them with adenosine 5′-O-(3-thiotriphosphate), a nonhydrolyzable form of ATP, or decreased by treatment with apyrase, which degrades ATP. The percentage of Th17 cells measured in a co-culture of T cells and DCs was strongly increased by the addition of bacterial supernatant, and this effect was apyrase dependent, demonstrating that Th17 cell differentiation is markedly influenced by bacterially dependent ATP in the intestinal mucosa.
Accordingly, the ATP released by activated Tregs triggered a decrease in the Foxp3 protein (a Treg-associated transcription factor) and polarized the cells susceptible of conversion to Th17 cells through the activation of P2X7 receptors. This supports a role for autocrine ATP in modulating Treg-mediated immunosuppression and lineage stability, and in acting on the fine-tuning of the developmental and immunosuppressive program of the T cells in adaptive immune responses. [36] In a direct manner, P2X7 receptor was shown to be effectively involved in T-cell activation since the ATP release was required for TCR-mediated calcium influx and IL-2 production. Using Jurkat T cells, the removal of extracellular ATP by apyrase or the use of small interfering RNA (siRNA) silencing of P2X7 receptors blocked calcium influx and, consequently, inhibited T-cell activation. [37] The same group of researchers also demonstrated that pannexin-1 hemichannels, together with P2X1 and P2X4 receptors facilitated ATP release and calcium entry, thus regulating T-cell activation. [38] Besides other functions, the P2X7 receptor seems to regulate the uptake of foreign particles or bacteria, and after a few minutes, extracellular ATP increases, firstly to limit excessive phagocytosis by the macrophage and secondly to promote the release of pro-inflammatory cytokines. [39] It was demonstrated that P2X7 receptor controls Chlamydia infection, for example, by directly inhibiting the infection in epithelial cells, rather than by the ability of P2X7 receptor to modulate IL-1β secretion. [40] Regarding specific bacterial infections such as those of Mycobacteria and Chlamydia, activated P2X7 receptor has been shown to be able to control the pathogen. [41] [42] [43] [44] Specifically in these models, P2X7 activation led to infection inhibition through fusion of vacuoles with lysosomes, which has been shown to promote vacuole acidification, a mechanism that needs the activation of host cell phospholipases. [42] Also, in macrophages infected with the protozoan Toxoplasma gondii, ATP was shown to mediate pathogen elimination through acidification of the parasitophorous vacuole. [45, 46] Also, it was reported that in Leishmania amazonensis infection of macrophages, a P2X7 receptor upregulation was induced, which, when activated by ATP, reduced the pathogen load and, consequently, the cell death. [47] It was shown that the control of L. amazonensis infection mediated by P2X7 receptor activation involves production of leukotriene B4 (LTB4) by a mechanism dependent on the enzyme, 5-lipoxygenase (unpublished data). Recently, a study using a macrophage-epithelial cell co-culture system during viral infection has demonstrated that ATP signaling through P2X7 receptor is required for the induction of inflammatory mediators by inflammasome activation, since inhibition or deficiency of P2X7, as well as caspase-1, significantly reduces IL-1β secretion. [48] In relation to P2X7 function regulation, a P2X7 variant with apoptosis inhibitory actions has already been identified in humans, which demonstrated a distinct regulatory property for a truncated variant to antagonize its full-length counterpart through hetero-oligomerization. This was suggested to represent a possibility for regulation of a protein function by its variant. [49] It was demonstrated that interferon-gamma (IFN-γ) treatment, inducing a pro-inflammatory state in HeLa cells, was associated with a change in the functional state of the P2X7 receptor, upregulating the expression of its functional variant and downregulating the expression of truncated form. [50] Also, in a cancer study utilizing the chemotherapeutic agent Anthracycline, individuals treated for breast cancer and carrying a loss-of-function allele of P2X7 receptor developed metastatic disease more rapidly than the individuals presenting the normal allele. [51] Conditions linked to P2X7 receptor gene polymorphisms include tuberculosis susceptibility, resistance to infection by Chlamydia trachomatis, and increased fracture risk in post-menopausal women. [ 
52]

The modified role of P2X7 in chronic infection
It is well known that ATP ligation to P2X7 receptors serves as an important secondary stimulus for the IL-1β cleavage and secretion from pro-inflammatory cells, as previously reviewed elsewhere. [21] Furthermore, P2X7 receptor activation may function as a danger signal in the context of tissue trauma. [53] However, the role of P2X7 in the chronic exposure to ATP and chronic infection is still poorly explored. Chronic exposure to low (micromolar) concentrations of extracellular ATP might work as a negative feedback to impair dendritic cells' contribution to exacerbated inflammation. In the proximity of injured cells, where the concentration may be in the micromolar range, ATP can block the synthesis of pro-inflammatory cytokines and chemokines by the DCs required for the recruitment of NK cells and type 1 polarized T cells. In other words, this can restrict dendritic cells' capacity to induce a Th1 response. As a result, the development of less self-harmful type 2 responses is privileged. [53] In an in vivo model of diabetes mellitus, the expression of P2X7 in the pancreas of early-and late-developed diabetes was investigated. [54] A differential pattern of P2X7 receptor expression was found, since in early-developed diabetes, P2X7 receptor expression changed from an annular expression around the pancreatic islets to a more diffuse pattern. In late-developed diabetes, P2X7 receptors were downregulated. [54] P2X7 receptor role was also evaluated in the process of interstitial inflammation and fibrosis, tubular atrophy, and renal cell apoptosis. [55] This study highlighted the involvement of these receptors in the process of interstitial inflammation and collagen deposition in response to ureteral obstruction, indicating that P2X7 receptor can be upregulated in the initial stages of renal inflammation but downregulated as the chronic obstruction persists. [55] In accordance with this, recent data also showed a downregulation of P2X7 receptor in schistosomiasis infection, an intravascular disease associated with inflammation, which likely limits the infection-related endothelial damage. [56] Using both in vitro and in vivo models, colchicine has been documented to block the pro-inflammatory signaling downstream of P2X7 receptor activation. It was suggested that the dye uptake associated with the activation of P2X7 receptors is distinct from the P2X7 receptor ion channel and could be a therapeutic target for the treatment of chronic inflammation. [57] Recent studies using gene knockout mice and selective P2X7 receptor antagonists suggest that P2X7 receptor is a viable therapeutic target for inflammatory diseases. However, efficacious P2X7 receptor antagonists for use in clinical studies are still at an early stage of development. Future challenges include identifying the potential toxicity and side effects of the P2X7 antagonists, as well as their duration in chronic inflammatory conditions, as reviewed elsewhere. [58] The role of ectonucleotidases in the P2X7 functionality in inflammation and infection Since ATP and other nucleotides (e.g. UTP and NAD+) are released from immune and non-immune cells during inflammation, infection, and tissue damage, [25, [59] [60] [61] the presence of nucleotide-metabolizing pathways on the surface of these cells is essential for the sophisticated regulation of the composition, duration, intensity, and magnitude of purinergic signaling. [62] The proteins located on the cell surface which are responsible for this control of purinergic signaling are a group of enzymes named ectonucleotidases. The ecto-nucleoside triphosphate diphosphohydrolases (E-NTPDases), ecto-nucleotide pyrophosphatase/phosphodiesterases (E-NPPs), and ecto-5′-nucleotidase are the most relevant ectonucleotidases in the innate immunity context [63, 64] [ Figure 1 ] and are discussed in this review.
Ecto-nucleoside triphosphate diphosphohydrolases
E-NTPDases hydrolyze extracellular tri-and diphosphonucleosides to monophosphonucleosides, and eight different enzymes are described as members of this family. [65] NTPDase1/CD39, NTPDase2/CD39L1, NTPDase3/ CD39L3, and NTPDase8 are ectoenzymes tightly bounded to the plasma membrane through two transmembrane domains. [63, 66] On the other hand, the NTPDase4, NTPDase5, NTPDase6, and NTPDase7 show intracellular localization. Among them, NTPDase5 and NTPDase6 present only an N-terminal transmembrane domain described as a possible cleavage site; therefore, these intracellular NTPDases can be shed and released into the extracellular medium. [64, 67, 68] E-NTPDase1 hydrolyzes ATP and ADP equally well, while E-NTPDases2, 3, and 8 prefer to hydrolyze ATP over ADP. Of note, E-NTPDase1/CD39 is the dominant ectonucleotidase in immune cells, while E-NTPDase8 is highly expressed only in the liver, kidney, and jejunum. [63, 69] Since ATP pro-inflammatory signaling through P2X7 receptor can be terminated by the action of E-NTPDases, a role for these enzymes in inflammation and infection has become more accepted over the last few years. Different groups have reported the importance of E-NTPDases in regulating the extracellular nucleotide levels and, consequently, the P2 receptor activities during inflammatory conditions. [62, 70] Levesque et al., [71] demonstrated that E-NTPDase1/CD39 is the major ectonucleotidase expressed in macrophages, and that this enzyme can modulate in vitro cellular responses, such as apoptosis and IL-1β and IL-18 release, through P2X7 receptor activation. Also, Zanin et al., [72] have shown that the activity and gene expression of E-NTPDases decrease in pro-inflammatory M1 macrophages, suggesting an accumulation of extracellular ATP, which is relevant for NLRP3 inflammasome activation and IL-1β release. By contrast, M2 macrophages showed an increased nucleotide catabolism and E-NTPDases expression, reducing the ATP availability and generating an adenosine-rich immunosuppressive environment. Recently, Cohen et al., [22] also reported that the TLR receptor activation induces ATP release, which is rapidly broken down into adenosine by E-NTPDase1/CD39, reducing the macrophage activation. Also, using a mouse model of sepsis, the same authors demonstrated the importance of ATP hydrolysis during inflammatory responses, where E-NTPDase1-deficient macrophages induce lethal endotoxic shock. Furthermore, Téâtre et al., [73] showed that the overexpression of CD39 in airway epithelia can protect against Pseudomonas aeruginosa infection, thus providing evidences that E-NTPDases are also crucial to prevent the desensitization of P2 receptors, since high extracellular nucleotide levels may induce this phenomenon and, consequently, impair a pro-inflammatory response through the activation of these receptors. Therefore, these reports suggest that the functionality of ectonucleotidases impacts the macrophage functions and that a sophisticated control of E-NTPDase activities is essential for a beneficial immune response during inflammation and infection.
The extracellular ATP acting through P2X7 receptor plays a key role in the host resistance to infection by microbial pathogens, as discussed earlier. Interestingly, several reports have shown that pathogens can exploit the host cell ectonucleotidases, which scavenge extracellular ATP, reducing the microbicidal responses triggered by P2X7 receptor activation. [74] Studies have reported an increase in E-NTPDases' activity and expression in lymphocytes of patients infected with human immunodeficiency virus, [75, 76] as well as in endothelial cells infected with cytomegalovirus. [77] Moreover, studies have shown that several pathogens express ectonucleotidases, which favors their invasion and dissemination in the host. Firstly, Crane et al., [78] demonstrated a rapid breakdown of the released ATP in response to enteropathogenic Escherichia coli infection. Sansom et al., [79] reported that the bacteria Legionella pneumophila are equipped with an E-NTPDase similar to human CD39, which facilitates the entry of the bacteria in host macrophages and epithelial cells. Also, Zebisch et al., [80] recently reported a new crystal form of E-NTPDase1 in this bacterium. Porphyromonas gingivalis, in turn, secretes a homolog of nucleoside diphosphate kinase (Ndk), which can inhibit P2X7-mediated apoptosis in macrophages or primary gingival epithelial cells. [81, 82] Secondly, fungi, such as Saccharomyces cerevisiae, Candida parapsilosis, and Cryptococcus neoformans that can cause pneumonia and meningoencephalitis, also have ectoenzymes that hydrolyze ATP and generate adenosine. Finally, E-NTPDase activities have been described in protozoan parasites belonging to the genera Leishmania, Trichomonas, Trypanosoma, and Toxoplasma, and the activities of these enzymes have been correlated to the establishment and propagation of these protozoan infections. [83] [84] [85] [86] Ecto-nucleotide pyrophosphatase/ phosphodiesterases E-NPP family presents seven structurally related ectoenzymes, but only the first three members (E-NPP1-3) are relevant in the context of the purinergic signaling cascade. These enzymes are able to hydrolyze pyrophosphate and phosphodiester bonds in a wide range of substrates, such as tri-and diphosphonucleosides, nucleic acids, nucleotide sugars, as well as in choline phosphate esters and lysophospholipids. [87, 88] Studies have suggested that the E-NPPs also play an important role in the modulation of purinergic signaling during inflammation by hydrolyzing extracellular Biomed J Vol. 37 No. 4 July -August 2014 pro-inflammatory nucleotides and generating extracellular pyrophosphates. [87, 89] Pelegrin and Suprenant demonstrated that pyrophosphates can inhibit caspase-1 activation and IL-1β release, [90] suggesting that these molecules are able to block the inflammasome activation. In addition, pyrophosphates reduce the pro-inflammatory cytokine production during peritonitis. [91] Interestingly, the E-NPP activities and gene expression increase 24 and 48 h after the LPS-induced endotoxemia in mice lymphocytes and kidney membrane preparations. [92, 93] Moreover, a recent study showed that the E-NPP activities increase in the platelets of patients with indeterminate form of Chagas' disease, indicating the role of these enzymes in protozoan pathogens invading the bloodstream. [94] By contrast, Vuaden et al., [95] demonstrated that 48 h of induced endotoxemia promotes a decrease in E-NPP activities in rat platelets and a reduction in platelet aggregation. Finally, Lopez-Castejón et al., [91] reported that the NPP-1 is highly expressed in M2 compared to M1 macrophages, while an exacerbated NPP-2 (autotaxin) and NPP-3 expression is associated with several types of cancer. [96] [97] [98] Taken together, these reports might suggest that E-NPPs can impair the P2X7 receptor functionality and contribute to the resolution of inflammation by producing extracellular pyrophosphates.
Ecto-5′-nucleotidase (CD73)
The ecto-5′-nucleotidase/CD73 is a glycosylphosphatidylinositol-anchored enzyme responsible for AMP hydrolysis, thus generating adenosine, the final product of ATP breakdown. [99] Ecto-5′-nucleotidase (CD73) is classically a lymphocyte maturation marker which is involved in intracellular signaling, lymphocyte proliferation and activation. [100, 101] Although ecto-5′-nucleotidase/CD73 is not directly related to the P2X7 receptor functionality, the opposing effects of adenosine and ATP on the immune cells suggest an important role for this enzyme in innate immunity context. Importantly, different authors have reported that this enzyme can also modulate macrophage, neutrophil, and dendritic cell functions. [30, 72, 100, 102] Regarding this, several studies have demonstrated the importance of ecto-5′-nucleotidase/ CD73 in generating an adenosine-rich environment in inflammation and infection, as detailed further in several recent reviews. [62, 70, 103] Concluding remarks P2X7 receptor has been widely investigated, especially with regard to its participation in the innate immune response. Much of the recent data in the literature provides evidence showing that this receptor is not only involved in pore formation and control of cellular apoptosis, but also can actively act together with other mediators in the initiation of inflammation, control of infection, and regulation of adaptive T-cell activation. The fine-tuning of P2X7 receptor function is markedly affected by the time of exposure and quantity of extracellular ATP which is shown to be tightly regulated by the action of ectonucleotidases. As such, P2X7 receptor not only represents an interesting therapeutic target in infectious inflammatory diseases, but also continues to represent a focus for future research regarding its regulation by these ectoenzymes, which in turn can direct the course of inflammation.
